Staging of Small Cell Lung Cancer: What You Need to Know

Small cell lung cancer (SCLC) is a fairly aggressive type of cancer. Two-thirds of patients are diagnosed when the cancer has reached advanced and extensive stages. These individuals often end up in the emergency department due to the sudden onset of severe symptoms, such as difficulty breathing, chest pain and bloody cough.

A two-stage system was utilized to simplify the process of staging a rapidly progressing disease like SCLC. This approach also allowed for distinct treatment regimens to be implemented for each stage. Thus, patients could receive the most appropriate and effective care for their specific condition.

Take a look at the table below that shows the different stages of SCLC, namely limited and extensive.

Limited stage	Extensive stage
Corresponding to Tumor, Node, Metastasis (TNM) stages I-IIIB Only 1 out of 3 SCLC patients diagnosed at this stage	2 out of 3 SCLC patients diagnosed at this stage
Present in only one lung It may have spread to nearby lymph nodes or the space between the lungs (mediastinum) But has not metastasized to other regions of the body.	Present in both lungs It has metastasized to other sites in the body, such as the distant lymph nodes, bones, or the brain.
Patients might benefit from aggressive treatments, such as a combination of chemotherapy and radiotherapy Must be confined to one radiation “port” or one treatment field With a goal to cure Median survival of about 15-20 months after treatment	A combination of chemotherapy and immunotherapy Palliative radiotherapy for pain relief With a goal of controlling and relieving symptoms Median survival of about 8-13 months

Click to see full list

Besides the two-stage system, SCLC is also classified using the TNM staging system. However, it is important to note that TNM staging does not affect clinical management since the majority of patients are diagnosed at an advanced stage. This highlights the need for early detection methods to improve patient outcomes and combat the challenges SCLC poses.

Due to the rapid doubling time of SCLC, immediate treatment is crucial to improve patient survival. It is important not to postpone treatment while conducting the staging workup. Therefore, even for symptomatic patients, treatment can start while the staging workup progresses.

A complete staging workup may include the following:

• Physical examination
• Blood count and other chemical profiles
• Computed tomography (CT) scan of the chest, abdomen, and pelvis
• Magnetic resonance imaging (MRI) or CT scan of the brain
• Positron emission tomography (PET)-CT scan. It is more sensitive than a CT scan, as it involves an injection of radioactive sugar. A cancerous site or tumor takes up more sugar than healthy cells. The PET scan detects areas with high levels of radioactive sugar, while the CT scan takes X-ray images from different angles. PET-CT is especially useful for detecting smaller tumors at the limited stage or lymph nodes that turn cancerous.

SCLC can be quite a fast-advancing disease, and it is important to start treatment as soon as possible. This process may be overwhelming. Instead, shift your focus to staying well-informed and approach the situation step by step. Take the time you need to comprehend every piece of information that comes your way fully. If any concerns or questions arise, do not hesitate to seek advice and guidance from medical professionals with the expertise to address any doubts. They can also provide the necessary support and reassurance you may seek. This knowledge and aid can give you the confidence to navigate this challenging time.

Related: If You Have Small Cell Lung Cancer (SCLC)